Literature DB >> 327013

Trypanosoma cruzi: the immunological induction of macrophage plasminogen activator requires thymus-derived lymphocytes.

N Nogueira, S Gordon, Z Cohn.   

Abstract

In this article we describe methods in which unstimulated mouse peritoneal macrophages were induced to secrete high livels of plasminogen activator under in vitro conditions. The exposure of sensitized peritoneal or spleen cell populations from Trypanosoma cruzi-infected animals to either viable or heat-killed trypanosomes lead to the release of an inducing factor(s). Maximal levels of plasminogen activator secretion are achieved by the incubation of such factors (s) with unstimulated macrophages for 48 h. A significant increase in enzyme secretion was already observed after a 24 h incubation. The production of the inducing factor(s) by sensitized cells was immunologically specific and unrelated antigens did not stimulate the production of the factor(s) by sensitized peritoneal or spleen cell populations. The inducing factor(s) was produced by nylon-wool-fractionated spleen and peritoneal cells which had been depleted of marcrophages. Pretreatment of sensitized spleen cells with anti-theta serum and C abolished the production of the activating factor(s). The active supernatant fluids were able to induce secretion of macrophage plasminogen activator across H-2 barriers. Attempts to induce trypanocidal activity in unstimulated macrophages have not been successful.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 327013      PMCID: PMC2180732          DOI: 10.1084/jem.146.1.172

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  [Cellular aspects of immunity in Chagas disease].

Authors:  T PIZZI; M RUBIO
Journal:  Bol Chil Parasitol       Date:  1955 Jan-Mar

2.  Cultural and physiological observations on Trypanosoma rhodesiense and Trypanosoma gambiense.

Authors:  E J TOBIE; T VON BRAND; B MEHLMAN
Journal:  J Parasitol       Date:  1950-02       Impact factor: 1.276

3.  Production of lymphotoxin and migration inhibitory factor by established human lymphocytic cell lines.

Authors:  G A Granger; G E Moore; J G White; P Matzinger; J S Sundsmo; S Shupe; W P Kolb; J Kramer; P R Glade
Journal:  J Immunol       Date:  1970-06       Impact factor: 5.422

4.  Production of migration inhibitory factor and lymphotoxin by non-T cells.

Authors:  B R Bloom; G Stoner; J Gaffney; E Shevach; I Green
Journal:  Eur J Immunol       Date:  1975-03       Impact factor: 5.532

5.  Pinocytic rates of macrophages from mice immunized against Toxoplasma gondii and macrophages stimulated to inhibit toxoplasma in vitro.

Authors:  T C Jones; L Len
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

6.  Macrophage plasminogen activator: induction by products of activated lymphoid cells.

Authors:  J D Vassalli; E Reich
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

7.  Effect of normal and activated human macrophages on Toxoplasma gondii.

Authors:  S E Anderson; J S Remington
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

8.  Trypanosoma cruzi: modification of macrophage function during infection.

Authors:  N Nogueira; S Gordon; Z Cohn
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

9.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

10.  THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES. MORPHOLOGY, CYTOCHEMISTRY, AND BIOCHEMISTRY.

Authors:  Z A COHN; B BENSON
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

View more
  19 in total

1.  Effect of gamma interferon on hydrogen peroxide production by cultured mouse peritoneal macrophages.

Authors:  A K Sharp; D K Banerjee
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

2.  Thymus-derived lymphocytes control the expression of immunogenic properties of peritoneal macrophages.

Authors:  E Tzehoval; S Segal; M Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

Review 3.  Macrophage proteases and rheumatic diseases: regulation of plasminogen activator by thymus-derived lymphocytes.

Authors:  S Gordon; W Newman; B Bloom
Journal:  Agents Actions       Date:  1978-01

Review 4.  Proteinases in inflammatory demyelinating disease.

Authors:  C T Bever; J N Whitaker
Journal:  Springer Semin Immunopathol       Date:  1985

5.  Interactions between murine macrophages and obligate intracellular protozoa.

Authors:  T C Jones
Journal:  Am J Pathol       Date:  1981-01       Impact factor: 4.307

Review 6.  Macrophage activation, chronic inflammation and gastrointestinal disease.

Authors:  A R Tanner; M J Arthur; R Wright
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

7.  Dissociation of bactericidal activity from other functions of activated macrophages in exudates induced by thioglycolate medium.

Authors:  G L Spitalny
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

8.  Lung injury induced by leukocytic proteases.

Authors:  A Janoff; R White; H Carp; S Harel; R Dearing; D Lee
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

9.  Bacille Calmette-Guérin infection in the mouse. Regulation of macrophage plasminogen activator by T lymphocytes and specific antigen.

Authors:  S Gordon; Z A Cohn
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  Trypanosoma cruzi: enhanced alpha-macroglobulin levels correlate with the resistance of BALB/cj mice to acute infection.

Authors:  T C Araujo-Jorge; M J Lage; M T Rivera; Y Carlier; F Van Leuven
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.